From: A Paradoxical Role for Myeloid-Derived Suppressor Cells in Sepsis and Trauma
Study | Disease | MDSC classification | Additional markers used |
---|---|---|---|
Gabrilovich et al., J. Immunol. 2001 (57) | Cancer | Gr-1+, CD11b+ | MHCII |
Sinha et al., J. Immunol. 2005 (58) | Cancer | Gr-1+, CD11b+ | MHC II, CD80/86, F4/80, CD11c, |
Makarenkova et al., J. Immunol. 2006 (48) | Trauma | Gr-1+, CD11b+ | MHC II, CD80/86, F4/80, CD11c, CD31 |
Delano et al., J. Exp. Med. 2007 (12) | Sepsis | Gr-1+, CD11b+ | MHCII, CD31 |
Zhu et al., J. Immunol. 2007 (56) | Experimental autoimmune encephalomyelitis | Ly6C+, Ly6G+, Gr-1+, CD11b+ | MHCII, CD80/86, F4/80, CD11c, CD31 |
Noel et al., Shock 2005 (31) | Burn | Gr-1+, CD11b+ | F4/80, CD115, CD117 |
Youn et al., J. Immunol. 2008 (14) | Cancer | Ly6C+, Ly6G+, Gr-1+, CD11b+ | CD80, CD115, CD124, PD-L1 |
Dolcetti et al., Eur. J. Immunol. 2010 (59) | Cancer | Ly6C+, Ly6G+, Gr-1+, CD11b+ | F4/80, CD11c, CD31, CD124 |